Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 434 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Cannabinoids Clear all

Conditions: Osteoarthritis, Knee
Interventions: Dronabinol, Placebo; Drug · Other
Lead sponsor: Colorado Joint Replacement; Other
Eligibility: 21 Years to 75 Years
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Marijuana Smoking
Interventions: Smoked marijuana cigarettes: High THC dose (6% THC); Drug
Lead sponsor: Brown University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Cannabis Use Disorder
Interventions: Cannabidiol oral solution, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 25 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Immune System and Related Disorders, Immune System Diseases
Interventions: Cannabidiol (CBD); Dietary Supplement
Lead sponsor: NextEvo Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Psychosis, Cannabis Use, THC, Marijuana, Schizophrenia
Interventions: Placebo, Very Low Dose THC, Low Dose THC; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2026
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Epilepsy
Interventions: cannabidiol extract; Drug
Lead sponsor: University of Mississippi, Oxford; Other
Eligibility: 21 Years to 55 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: University, Mississippi

Conditions: Gastroparesis, Dyspepsia
Interventions: Cannabidiol, placebo; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Trichotillomania, Skin-Picking
Interventions: Dronabinol, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Social Anxiety Disorder
Interventions: Cannabidiol oral solution, Placebo; Drug
Lead sponsor: EmpowerPharm Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 17
States / cities: Encino, California • Lemon Grove, California • Los Alamitos, California + 14 more

Conditions: Seizure in Participants With Tuberous Sclerosis Complex, Seizure in Participants With Dravet Syndrome, Seizure in Participants With Lennox-Gastaut Syndrome
Interventions: GWP42003-P; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 1 Month to 23 Months
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Little Rock, Arkansas • Los Angeles, California • Chicago, Illinois + 3 more

Conditions: Cancer, Breakthrough Cancer Pain
Interventions: PPP001, Morphine sulfate or Hydromorphone or Oxycodone; Drug
Lead sponsor: Tetra Bio-Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Berlin, New Jersey

Conditions: CB1, Cannabinoid, PET, Brain Imaging
Interventions: [18F]FMPEP-d2; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Oncologic Complications, Quality of Life, Nutrition Poor, Head and Neck Cancer, Lung Cancer, Pancreatic Cancer
Interventions: Dexamethasone, Dronabinol, Mirtazapine, Nutrition Intervention; Drug · Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Cannabis, Alcohol Effect, Driving Under the Influence of Alcohol and Other Drugs
Interventions: Active delta-9-THC, Placebo, Active Ethanol; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Cannabis Use Disorder
Interventions: Dronabinol, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 45 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Anorexia Nervosa
Interventions: Cannabidiol, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: San Diego, California

Conditions: Cannabis, Psychotic Disorders
Interventions: THC, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 35 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Obsessive-Compulsive Disorder
Interventions: Nabilone, Placebo; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism, Autism Spectrum Disorder
Interventions: Epidiolex, placebo oral solution; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 7 Years to 14 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Multiple Sclerosis
Interventions: Inhaled Cannabis, Oral THC, Oral Placebo, Inhaled placebo; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 21 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury
Interventions: Cannabidiol, Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Marijuana Dependence
Interventions: Dronabinol; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chest Pain
Interventions: Marinol, Placebo; Drug
Lead sponsor: Yehudith Assouline-Dayan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Marijuana Smoking
Interventions: Inactive Marijuana (0% THC), Active Marijuana (5.5% THC), Active Marijuana (6.2% THC), Naltrexone, Placebo naltrexone; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 45 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint Arthroplasty

Behavioral Economic Analysis of Demand for Marijuana

SCORE Emerging Adult Cannabis Use & Stress

Study of Cannabidiol (CBD) in Healthy Volunteers

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

CBD Cannabis Extract: Pharmacokinetic Studies

Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia

Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain

PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2

Nutrition and Pharmacological Algorithm for Oncology Patients Study

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition

Endocannabinoids in Reward

Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa

Cannabinoids and Cerebellar-Motor Functioning

Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder

Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

Cannabis for Spasticity in Multiple Sclerosis

Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI

Ph1 Marinol Interaction Study - Part 1 - 1

The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain

Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana